Cite
HARVARD Citation
Hindley, C. et al. (n.d.). A combination vertical inhibition approach with inhibitors of SHP2 and ERK provides improved activity in KRAS-mutant pancreatic and colorectal cancer models. European journal of cancer. pp. S57-. [Online].